Skip to main content

Published locations for Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabine

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabine

User login

  • Reset your password
  • /content/rigosertib-falls-short-high-risk-myelodysplastic-syndromes-after-failure-azacitidine-or-0
  • /hematologynews/article/108018/myelodysplastic-syndrome/rigosertib-falls-short-high-risk
  • /oncologypractice/article/108018/myelodysplastic-syndrome/rigosertib-falls-short-high-risk
  • /hematology-oncology/article/108018/myelodysplastic-syndrome/rigosertib-falls-short-high-risk